Abstract
Atherosclerosis is the main cause of cardiovascular disease, but the extent of atherosclerosis in individual patients is difficult to estimate. A biomarker of the atherosclerotic burden would be very valuable. The aim of the present study was to evaluate the association of plasma osteoprotegerin (OPG) to clinical and subclinical atherosclerotic disease in a large community-based, cross-sectional population study. In the Copenhagen City Heart Study, OPG concentrations were measured in 5,863 men and women. A total of 494 participants had been hospitalized for ischemic heart disease or ischemic stroke, and compared to controls, this group with clinical atherosclerosis had higher mean OPG (1,773 vs 1,337 ng/L, p
| Original language | English |
|---|---|
| Journal | American Journal of Cardiology |
| Volume | 109 |
| Issue number | 4 |
| Pages (from-to) | 515-20 |
| Number of pages | 6 |
| ISSN | 0002-9149 |
| DOIs | |
| Publication status | Published - 2012 |
Keywords
- Adult
- Aged
- Aged, 80 and over
- Ankle Brachial Index
- Atherosclerosis
- Biological Markers
- C-Reactive Protein
- Case-Control Studies
- Cross-Sectional Studies
- Diabetes Mellitus
- Female
- Humans
- Hypercholesterolemia
- Hypertension
- Male
- Middle Aged
- Multivariate Analysis
- Osteoprotegerin
- Risk Factors
- Smoking
- Young Adult
Fingerprint
Dive into the research topics of 'Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS